4-butyrolactone has been researched along with cacospongionolide b in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crispino, A; De Giulio, A; De Rosa, S; Iodice, C; Pronzato, R; Zavodnik, N | 1 |
| Alcaraz, MJ; De Rosa, M; Giordano, S; Pastor, PG; Payá, M; Scettri, A; Sodano, G; Soriente, A | 1 |
| Alcaraz, MJ; De Giulio, A; De Rosa, S; García Pastor, P; Payá, M | 1 |
| Amodeo, P; Crispino, A; De Giulio, A; De Rosa, S; Iodice, C; Tancredi, T | 1 |
| Cheung, AK; Snapper, ML | 1 |
| Alcaraz, MJ; De Rosa, S; Payá, M; Posadas, I; Terencio, MC | 1 |
| Cheung, AK; Murelli, R; Snapper, ML | 1 |
| Cheung, AK; Murelli, RP; Snapper, ML | 1 |
| Carnuccio, R; De Rosa, S; De Stefano, D; Iodice, C; Maiuri, MC; Malik, SA; Tommonaro, G | 1 |
9 other study(ies) available for 4-butyrolactone and cacospongionolide b
| Article | Year |
|---|---|
Cacospongionolide B, a new sesterterpene from the sponge Fasciospongia cavernosa.
Topics: 4-Butyrolactone; Acetylation; Animals; Anti-Bacterial Agents; Artemia; Cyprinodontiformes; Gram-Negative Bacteria; Gram-Positive Bacteria; Lethal Dose 50; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Porifera; Pyrans | 1995 |
Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bee Venoms; Carrageenan; Cell Line; Cytosol; Drug Design; Edema; Elapid Venoms; Enzyme Inhibitors; Female; Humans; Kinetics; Mice; Molecular Structure; Pancreas; Phospholipases A; Phospholipases A2; Pyrans; Structure-Activity Relationship; Swine; Synovial Membrane; Terpenes | 1998 |
Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
Topics: 4-Butyrolactone; Acute Disease; Animals; Anti-Infective Agents; Arthritis, Experimental; Chronic Disease; Dose-Response Relationship, Drug; Ear; Edema; Enzymes; Female; Humans; Inflammation; Leukocytes; Male; Mice; Phospholipases A; Phospholipases A2; Pyrans; Rats; Rats, Wistar; Synovial Fluid; U937 Cells | 1999 |
A new cacospongionolide derivative from the sponge Fasciospongia cavernosa.
Topics: 4-Butyrolactone; Animals; Anti-Infective Agents; Microbial Sensitivity Tests; Molecular Structure; Porifera; Pyrans; Spectrum Analysis | 1999 |
Total syntheses of (+)- and (-)-cacospongionolide B: new insight into structural requirements for phospholipase A(2) inhibition.
Topics: 4-Butyrolactone; Enzyme Inhibitors; Phospholipases A; Pyrans; Stereoisomerism | 2002 |
Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Female; Gene Expression Regulation, Enzymologic; Mice; NF-kappa B; Porifera; Pyrans; Tumor Necrosis Factor-alpha | 2003 |
Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition.
Topics: 4-Butyrolactone; Animals; Enzyme Inhibitors; Molecular Structure; Phospholipases A; Phospholipases A2; Porifera; Pyrans; Stereoisomerism; Structure-Activity Relationship | 2004 |
Conformationally restricted (+)-cacospongionolide B analogues. Influence on secretory phospholipase A2 inhibition.
Topics: 4-Butyrolactone; Animals; Bee Venoms; Enzyme Inhibitors; Furaldehyde; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Phospholipases A; Phospholipases A2; Porifera; Pyrans; Recombinant Proteins | 2007 |
Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines.
Topics: 4-Butyrolactone; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Aquatic Organisms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; DNA Fragmentation; Homosteroids; Humans; NF-kappa B p50 Subunit; Porifera; Pyrans; Sesterterpenes; Transcription Factor RelA | 2012 |